Investment Banking Team

Nicholas Stergis

Managing Director

nstergis@ladenburg.com

Mr. Stergis has extensive transactional experience in the healthcare industry, having served in leadership positions and as a principal investor in both public and private companies. He has also founded several biotech companies which became public. Prior to joining Ladenburg Thalmann, he was the CEO and Vice Chair of the Board at Adeona Pharmaceuticals, currently Synthetic Biologics (NYSE AMEX:SYN). Previously, he served as Founder and Vice Chair of Encode Pharmaceuticals, which later merged with Raptor Pharmaceuticals (Nasdaq:RPTP). He was also a Co-Founder and Managing Director at Accredited Ventures and an Investment Associate at Paramount Capital. Mr. Stergis holds a master’s degree in Biology from NYU and a bachelor’s degree in Biology from SUNY (Albany).

Peter Blum

Peter Blum

Co-Chief Executive Officer and Co-President of Ladenburg

Steve Kaplan

Steve Kaplan

Managing Director and Head of Capital Markets

David J. Strupp, Jr.

David J. Strupp, Jr.

Managing Director & Head of Healthcare Investment Banking
Ladenburg Thalmann & Co.

Mark Green

Mark Green

Managing Director and Head of Technology Banking

Vlad Ivanov

Vlad Ivanov

Managing Director, Healthcare Investment Banking

Barry Steiner

Barry Steiner

Managing Director

Jonathan Intrater

Jonathan Intrater

Managing Director

Lionel Leventhal

Lionel Leventhal

Managing Director